View the BIG 100 largest medical device companies in the world listings here
BD (Medical segment)2022 Rank: 14
2021 Rank: n/a*
Franklin Lakes, New Jersey
2022 Revenues ($USD) : $9,479,000,000
2022 R&D spend : n/a
2022 Number of Employees : 30,000
Fiscal Year End : 9/30/2021
Company CEO : Tom Polen, chair, CEO and president.
The company’s medical segment, which previously included the diabetes business, underwent a number of changes at the top in 2022. First, there was the appointment of Simon Campion as EVP and president of the medical segment. BD announced in March that Alberto Mas intended to retire from the role. Campion’s position was made effective on July 1, 2022, but he spent less than two months running the segment, departing in late August for the corner office at Dentsply Sirona. Mike Garrison, who has been the worldwide president of BD Medication Management Solutions since 2020, will now be the new medical segment president.
In July, BD added to its offerings when it acquired Parata Systems for more than $1.5 billion. Parata provides medication adherence packaging technology and perpetual inventory management, with its automation technology and software designed to enable pharmacists to focus more on clinical work and patient interactions. The company is also currently facing a shareholder lawsuit over its much-maligned Alaris infusion pump system. The lawsuit involves how the company communicated its performance amid increasingly serious issues with the platform. –SW
*The 2022 Big 100 report is moving to September versus November in previous years. Because its fiscal year ends in September, BD's revenue number is the same as in the 2021 report.